WHO ICTRP trial
Active post marketing surveillance to evaluate the safety and efficacy of…
CTRI/2021/11/037912 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/11/037912 |
|---|---|
| Public title | Active post marketing surveillance to evaluate the safety and efficacy of Sinarest Syrup in children of common cold or allergic rhinitis. |
| Scientific title | A multicentric, non-randomized, open label, non-comparative, active post marketing surveillance to evaluate the safety and efficacy of Sinarest Syrup in children of common cold or allergic rhinitis. |
| Primary sponsor | Centaur Pharmaceuticals Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | PMS |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: J00- Acute nasopharyngitis [common cold] Health Condition 2: J309- Allergic rhinitis, unspecified |
| Interventions | Intervention1: Sinarest syrup: Sinarest syrup is a FDC of Paracetamol 125 mg, Phenylephrine Hydrochloride 5 mg, Chlorpheniramine Maleate 1 mg, Sodium citrate 60 mg and mentholated flavoured syrupy base q.s. per 5 ml which is indicated in… |
| Registration date | Oct 11, 2021 |
| Target size | 240 |
| Secondary IDs | 089-20 version 1.0, dated 20-January-2020 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: